News Archive: Partnerships

Patient-centred care, with its emphasis on patient value, is a widespread health system goal. To examine the progress of the evolution towards more patient-centred health care and draw lesson for the future, The Economist Intelligence Unit conducted a survey and interviews on patient...
Contributed by Camilla Krogh Lauritzen, Chief Patient Officer, LEO Pharma 28 February is Rare Disease Day. Hardly any surprise to anyone who is committed to changing the status quo for the millions of people affected by one or more of the 7000+ rare diseases. But then again, it may be news for many...
A new roadmap has been published identifying key priority areas that need to be addressed to tackle the burden of asthma. The roadmap, which has come out of the European Asthma Research and Innovation Partnership (EARIP) , suggests that a unified approach to research is urgently needed to address the challenge of asthma in Europe and improve the lives of people living with the condition.
The International Prevention Research Institute (iPRI) President Professor Peter Boyle signed an important Memorandum of Understanding with our Chair of the Board Jolanta Bilińska to mark the World Cancer Day. The role of patients’ organizations is morphing rapidly from its initial lobbying focus...
New Year is a great time for change and growth. Nittita Prasopa-Plaizier, our designated technical officer (DTO) for the WHO-IAPO official relationship, will move on to bigger and better things in 2017. Many of you met Nittita at our Global Patient Congress in April 2016. Nittita was the Programme...
On 1st January 2017, a new era begins at the United Nations. Mr. António Guterres, the former Portuguese prime minister, will become the next UN Secretary General, replacing Ban Ki-moon. http://bit.ly/2hhWEpq Mr. Guterres was the Prime Minister of Portugal from 1995 to 2002 and the UN High...
IAPO Governing Board Member Matthias Wienold wrote a blog for the British Medical Journal about online patient groups and the value they bring.
We are very pleased to announce that IAPO’s official relations status with the World Health Organization has been renewed.
IAPO and Advocates for International Development (A4ID), set up by 1,000 London based legal firms to provide pro-bono legal services to international NGOs in their development work, have formed a partnership to improve our members’ access to legal expertise to increase their impact in low and middle-income countries.
We are delighted to share that IAPO has recently formalized its partnership with Alianza Latina, through the signing of a Memorandum of Understanding.
The World Health Organization (WHO) has nominated IAPO Governing Board member Mr. Hussain Jafri as the Vice Chair of the Advisory Group of WHO's Patients for Patient Safety programme ( PFPS ) .
IAPO Governing Board member Eva Maria Ruiz de Castilla attended the 16th International Conference of Drug Regulatory Authorities in Rio de Janeiro, Brazil in August 2014, and a pre-conference on 'Ensuring Quality and Safety of Biosimilars for Patients Worldwide'. Eva Maria spoke during a plenary...
What if we could build a system of patient-centered cancer care with all the innovations we could possibly imagine? Contributed by Rebekkah Schear, Program Manager, the LIVESTRONG Foundation (IAPO member).